SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: R>G> who wrote (3065)	7/12/1998 8:09:00 PM
From: Prospector	of 5402

Advisory Board Herbert J. Meiselman Sc.D He is Professor of Physiology and Biophysics at the University of Southern California School of Medicine and authority on surfactant and the rheology of blood. He has published many articles relating to synthetic blood, including "Hemorheological Effects of a Nonionic Copolymer Surfactant,"Clinical Hemorheology, 1992: Effects of Cellular Morphology on the Viscoelastic Behavior of High Hematocrit Red Blood Cell Suspensions, 26 Biorheology 153,1989; and Osmolality-mediated Fahraeus and Fahraeus-Lindquist Effects for Human Red Blood Cell Suspensions." 254 American Journal of Physiology H238, 1988.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next